Advanced search
Publication Cover
Expert Opinion on Biological Therapy Volume 8, 2008 - Issue 4
Submit an article Journal homepage
93
Views
1
CrossRef citations to date
0
Altmetric
Reviews

Surfactant protein D/anti-Fc receptor bifunctional proteins as a tool to enhance host defence

Esther CW Breij Utrecht University, Department of Biochemistry and Cell Biology, Veterinary Sciences Faculty, Yalelaan 2, 3584 CM Utrecht, The Netherlands +31 30 2532562; +31 30 2535492; [email protected]
, PhD &
Joseph J Batenburg Utrecht University, Department of Biochemistry and Cell Biology, Veterinary Sciences Faculty, Yalelaan 2, 3584 CM Utrecht, The Netherlands +31 30 2532562; +31 30 2535492; [email protected]
, PhD
Pages 409-419 | Published online: 19 Mar 2008

Bibliography

  • Moellering RC Jr, Graybill JR, McGowan JE Jr, Corey L. Antimicrobial resistance prevention initiative – an update: proceedings of an expert panel on resistance. Am J Med 2007;120:S4-25
  • Sanglard D, Odds FC. Resistance of Candida species to antifungal agents: molecular mechanisms and clinical consequences. Lancet Infect Dis 2002;2:73-85
  • Deyde VM, Xu X, Bright RA, et al. Surveillance of resistance to adamantanes among influenza A(H3N2) and A(H1N1) viruses isolated worldwide. J Infect Dis 2007;196:249-57
  • Cheung CL, Rayner JM, Smith GJ, et al. Distribution of amantadine-resistant H5N1 avian influenza variants in Asia. J Infect Dis 2006;193:1626-9
  • Tacken PJ, Hartshorn KL, White MR, et al. Effective targeting of pathogens to neutrophils via chimeric surfactant protein D/anti-CD89 protein. J Immunol. 2004;172:4934-40
  • Voorhout WF, Veenendaal T, Kuroki Y, Ogasawara Y, Van Golde LM, Geuze HJ. Immunocytochemical localization of surfactant protein D (SP-D) in type II cells, Clara cells, and alveolar macrophages of rat lung. J Histochem Cytochem 1992;40:1589-97
  • Madsen J, Kliem A, Tornoe I, Skjodt K, Koch C, Holmskov U. Localization of lung surfactant protein D on mucosal surfaces in human tissues. J Immunol 2000;164:5866-70
  • Crouch E, Persson A, Chang D, Heuser J. Molecular structure of pulmonary surfactant protein D (SP-D). J Biol Chem 1994;269:17311-9
  • Kishore U, Greenhough TJ, Waters P, et al. Surfactant proteins SP-A and SP-D: structure, function and receptors. Mol Immunol 2006;43:1293-315
  • Van De Wetering JK, Van Golde LM, Batenburg JJ. Collectins: players of the innate immune system. Eur J Biochem 2004;271:1229-49
  • Leth-Larsen R, Garred P, Jensenius H, et al. A common polymorphism in the SFTPD gene influences assembly, function, and concentration of surfactant protein D. J Immunol 2005;174:1532-8
  • Leth-Larsen R, Holmskov U, Hojrup P. Structural characterization of human and bovine lung surfactant protein D. Biochem J 1999;343(Pt 3):645-52
  • Medzhitov R, Janeway C Jr. Innate immune recognition: mechanisms and pathways. Immunol Rev 2000;173:89-97
  • Hansen S, Holmskov U. Lung surfactant protein D (SP-D) and the molecular diverted descendants: conglutinin, CL-43 and CL-46. Immunobiology 2002;205:498-517
  • Drickamer K, Taylor ME. Evolving views of protein glycosylation. Trends Biochem Sci 1998;23:321-4
  • Weis WI, Taylor ME, Drickamer K. The C-type lectin superfamily in the immune system. Immunol Rev 1998;163:19-34
  • Van Rozendaal BA, Van Spriel AB, Van De Winkel JG, Haagsman HP. Role of pulmonary surfactant protein D in innate defense against Candida albicans. J Infect Dis 2000;182:917-22
  • Yong SJ, Vuk-Pavlovic Z, Standing JE, Crouch EC, Limper AH. Surfactant protein D-mediated aggregation of Pneumocystis carinii impairs phagocytosis by alveolar macrophages. Infect Immun 2003;71:1662-71
  • Ferguson JS, Voelker DR, Ufnar JA, Dawson AJ, Schlesinger LS. Surfactant protein D inhibition of human macrophage uptake of Mycobacterium tuberculosis is independent of bacterial agglutination. J Immunol 2002;168:1309-14
  • Restrepo CI, Dong Q, Savov J, Mariencheck WI, Wright JR. Surfactant protein D stimulates phagocytosis of Pseudomonas aeruginosa by alveolar macrophages. Am J Respir Cell Mol Biol 1999;21:576-85
  • Kudo K, Sano H, Takahashi H, et al. Pulmonary collectins enhance phagocytosis of Mycobacterium avium through increased activity of mannose receptor. J Immunol 2004;172:7592-602
  • Wu H, kuzmenko A, Wan S, et al. Surfactant proteins A and D inhibit the growth of Gram-negative bacteria by increasing membrane permeability. J Clin Invest 2003;111:1589-602
  • McCormack FX, Gibbons R, Ward SR, Kuzmenko A, Wu H, Deepe GS Jr. Macrophage-independent fungicidal action of the pulmonary collectins. J Biol Chem 2003;278(38):36250-6
  • Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005;5:58-68
  • Gardai SJ, Xiao YQ, Dickinson M, et al. By binding SIRPα or calreticulin/CD91, lung collectins act as dual function surveillance molecules to suppress or enhance inflammation. Cell 2003;115:13-23
  • Crouch EC, Persson A, Griffin GL, Chang D, Senior RM. Interactions of pulmonary surfactant protein D (SP-D) with human blood leukocytes. Am J Respir Cell Mol Biol 1995;12:410-5
  • Tino MJ, Wright JR. Surfactant proteins A and D specifically stimulate directed actin-based responses in alveolar macrophages. Am J Physiol 1999;276:L164-74
  • Hansen S, Lo B, Evans K, Neophytou P, Holmskov U, Wright JR. Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol 2007;36:94-102
  • Borron PJ, Mostaghel EA, Doyle C, Walsh ES, Heyzer-Williams MG, Wright JR. Pulmonary surfactant proteins A and D directly suppress CD3+/CD4+ cell function: evidence for two shared mechanisms. J Immunol 2002;169:5844-50
  • Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KB. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J Immunol 2002;169:2892-9
  • Wert SE, Yoshida M, Levine AM, et al. Increased metalloproteinase activity, oxidant production, and emphysema in surfactant protein D gene-inactivated mice. Proc Natl Acad Sci USA 2000;97:5972-7
  • Levine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001;167:5868-73
  • Levine AM, Elliott J, Whitsett JA, et al. Surfactant protein-d enhances phagocytosis and pulmonary clearance of respiratory syncytial virus. Am J Respir Cell Mol Biol 2004;31:193-9
  • Jounblat R, Clark H, Eggleton P, Hawgood S, Andrew PW, Kadioglu A. The role of surfactant protein D in the colonisation of the respiratory tract and onset of bacteraemia during pneumococcal pneumonia. Respir Res 2005;6:126
  • Giannoni E, Sawa T, Allen L, Wiener-Kronish J, Hawgood S. Surfactant proteins A and D enhance pulmonary clearance of Pseudomonas aeruginosa. Am J Respir Cell Mol Biol 2006;34:704-10
  • Atochina EN, Gow AJ, Beck JM, et al. Delayed clearance of pneumocystis carinii infection, increased inflammation, and altered nitric oxide metabolism in lungs of surfactant protein-D knockout mice. J Infect Dis 2004;189:1528-39
  • Hickling TP, Bright H, Wing K, et al. A recombinant trimeric surfactant protein D carbohydrate recognition domain inhibits respiratory syncytial virus infection in vitro and in vivo. Eur J Immunol 1999;29:3478-84
  • Madan T, Kishore U, Singh M, et al. Protective role of lung surfactant protein D in a murine model of invasive pulmonary aspergillosis. Infect Immun 2001;69:2728-31
  • Knudsen L, Ochs M, Mackay R, et al. Truncated recombinant human SP-D attenuates emphysema and type II cell changes in SP-D deficient mice. Respir Res 2007;8:70. Published online 3 October 2007, doi:10.1186/1465-9921-8-70
  • Kingma PS, Zhang L, Ikegami M, Hartshorn K, McCormack FX, Whitsett JA. Correction of pulmonary abnormalities in Sftpd-/- mice requires the collagenous domain of surfactant protein D. J Biol Chem 2006;281:24496-505
  • Clark H, Reid K. The potential of recombinant surfactant protein D therapy to reduce inflammation in neonatal chronic lung disease, cystic fibrosis, and emphysema. Arch Dis Child 2003;88:981-4
  • Clark H, Reid KB. Structural requirements for SP-D function in vitro and in vivo: therapeutic potential of recombinant SP-D. Immunobiology 2002;205:619-31
  • Otten MA, Van Egmond M. The Fc receptor for IgA (FcalphaRI, CD89). Immunol Lett 2004;92:23-31
  • Nimmerjahn F, Ravetch JV. Fcγ receptors: old friends and new family members. Immunity 2006;24:19-28
  • Fanger NA, Voigtlaender D, Liu C, et al. Characterization of expression, cytokine regulation, and effector function of the high affinity IgG receptor Fc gamma RI (CD64) expressed on human blood dendritic cells. J Immunol 1997;158:3090-8
  • Pasquier B, Lepelletier Y, Baude C, Hermine O, Monteiro RC. Differential expression and function of IgA receptors (CD89 and CD71) during maturation of dendritic cells. J Leukoc Biol 2004;76:1134-41
  • Otten MA, Groenveld I, Van De Winkel JG, Van Egmond M. Inefficient antigen presentation via the IgA Fc receptor (FcalphaRI) on dendritic cells. Immunobiology 2006;211:503-10
  • Guyre CA, Barreda ME, Swink SL, Fanger MW. Colocalization of Fc gamma RI-targeted antigen with class I MHC: implications for antigen processing. J Immunol 2001;166:2469-78
  • Heijnen IA, Van Vugt MJ, Fanger NA, et al. Antigen targeting to myeloid-specific human Fc gamma RI/CD64 triggers enhanced antibody responses in transgenic mice. J Clin Invest 1996;97:331-8
  • Van Spriel AB, Van Ojik HH, Van De Winkel JG. Immunotherapeutic perspective for bispecific antibodies. Immunol Today 2000;21:391-7
  • Honeychurch J, Tutt AL, Valerius T, Heijnen IA, Van De Winkel JG, Glennie MJ. Therapeutic efficacy of FcγRI/CD64-directed bispecific antibodies in B-cell lymphoma. Blood 2000;96:3544-52
  • Otten MA, Rudolph E, Dechant M, et al. Immature neutrophils mediate tumor cell killing via IgA but not IgG Fc receptors. J Immunol 2005;174:5472-80
  • Van Spriel AB, Van Den Herik-Oudijk IE, Van De Winkel JG. Neutrophil FcγRI as target for immunotherapy of invasive candidiasis. J Immunol 2001;166:7019-22
  • Hellwig SM, Van Spriel AB, Schellekens JF, Mooi FR, Van De Winkel JG. Immunoglobulin A-mediated protection against Bordetella pertussis infection. Infect Immun 2001;69:4846-50
  • Tacken PJ, Batenburg JJ. Monocyte CD64 or CD89 targeting by surfactant protein D/anti-Fc receptor mediates bacterial uptake. Immunology 2006;117:494-501
  • White MR, Crouch E, Vesona J, et al. Respiratory innate immune proteins differentially modulate the neutrophil respiratory burst response to influenza A virus. Am J Physiol Lung Cell Mol Physiol 2005;289:L606-16
  • Curnow RT. Clinical experience with CD64-directed immunotherapy. An overview. Cancer Immunol Immunother 1997;45:210-5
  • Madan T, Kishore U, Singh M, et al. Surfactant proteins A and D protect mice against pulmonary hypersensitivity induced by Aspergillus fumigatus antigens and allergens. J Clin Invest 2001;107:467-75
  • Sorensen GL, Madsen J, Kejling K, et al. Surfactant protein D is proatherogenic in mice. Am J Physiol Heart Circ Physiol 2006;290:H2286-94
  • Aapro MS, Cameron DA, Pettengell R, et al. EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer 2006;42:2433-53
  • Van Egmond M, Van Spriel AB, Vermeulen H, Huls G, Van GE, Van De Winkel JG. Enhancement of polymorphonuclear cell-mediated tumor cell killing on simultaneous engagement of fcγRI (CD64) and fcαRI (CD89). Cancer Res 2001;61:4055-60
  • Levine AM, Whitsett JA, Gwozdz JA, et al. Distinct effects of surfactant protein A or D deficiency during bacterial infection on the lung. J Immunol 2000;165:3934-40
  • Hartshorn KL, Crouch E, White MR, et al. Pulmonary surfactant proteins A and D enhance neutrophil uptake of bacteria. Am J Physiol 1998;274:L958-69
  • Kuan SF, Rust K, Crouch E. Interactions of surfactant protein D with bacterial lipopolysaccharides. Surfactant protein D is an Escherichia coli-binding protein in bronchoalveolar lavage. J Clin Invest 1992;90:97-106
  • Wu AM, Chen W, Raubitschek A, et al. Tumor localization of anti-CEA single-chain Fvs: improved targeting by non-covalent dimers. Immunotechnology 1996;2:21-36
  • Ofek I, Mesika A, Kalina M, et al. Surfactant protein D enhances phagocytosis and killing of unencapsulated phase variants of Klebsiella pneumoniae. Infect Immun 2001;69:24-33
  • Griese M, Starosta V. Agglutination of Pseudomonas aeruginosa by surfactant protein D. Pediatr Pulmonol 2005;40:378-84
  • Ferguson JS, Voelker DR, McCormack FX, Schlesinger LS. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages. J Immunol 1999;163:312-21
  • Chiba H, Pattanajitvilai S, Evans AJ, Harbeck RJ, Voelker DR. Human surfactant protein D (SP-D) binds Mycoplasma pneumoniae by high affinity interactions with lipids. J Biol Chem 2002;277:20379-85
  • Hartshorn K, Chang D, Rust K, White M, Heuser J, Crouch E. Interactions of recombinant human pulmonary surfactant protein D and SP-D multimers with influenza A. Am J Physiol 1996;271:L753-62
  • Meschi J, Crouch EC, Skolnik P, et al. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J Gen Virol 2005;86:3097-107
  • Reading PC, Holmskov U, Anders EM. Antiviral activity of bovine collectins against rotaviruses. J Gen Virol 1998;79:2255-63
  • Madan T, Eggleton P, Kishore U, et al. Binding of pulmonary surfactant proteins A and D to Aspergillus fumigatus conidia enhances phagocytosis and killing by human neutrophils and alveolar macrophages. Infect Immun 1997;65:3171-9
  • Lekkala M, Levine AM, Linke MJ, et al. Effect of lung surfactant collectins on bronchoalveolar macrophage interaction with Blastomyces dermatitidis: inhibition of tumor necrosis factor alpha production by surfactant protein D. Infect Immun 2006;74:4549-56
  • Schelenz S, Malhotra R, Sim RB, Holmskov U, Bancroft GJ. Binding of host collectins to the pathogenic yeast Cryptococcus neoformans: human surfactant protein D acts as an agglutinin for acapsular yeast cells. Infect Immun 1995;63:3360-6
  • Van De Wetering JK, Coenjaerts FE, Vaandrager AB, Van Golde LM, Batenburg JJ. Aggregation of Cryptococcus neoformans by surfactant protein D is inhibited by its capsular component glucuronoxylomannan. Infect Immun 2004;72:145-53
  • O'Riordan DM, Standing JE, Kwon KY, Chang D, Crouch EC, Limper AH.Surfactant protein D interacts with Pneumocystis carinii and mediates organism adherence to alveolar macrophages. J Clin Invest 1995;95:2699-710
  • Allen MJ, Voelker DR, Mason RJ. Interactions of surfactant proteins A and D with Saccharomyces cerevisiae and Aspergillus fumigatus. Infect Immun 2001;69:2037-44

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.